{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:26:38Z","timestamp":1788837998081,"version":"build-2803163510"},"reference-count":175,"publisher":"Bentham Science Publishers Ltd.","issue":"18","funder":[{"DOI":"10.13039\/501100002969","name":"Technological Agency of the Czech Republic","doi-asserted-by":"publisher","award":["TACR TH03030336"],"award-info":[{"award-number":["TACR TH03030336"]}],"id":[{"id":"10.13039\/501100002969","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2020,6,3]]},"abstract":"<jats:sec><jats:title\/><jats:p>Two cholinesterases exist: Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). While AChE plays a crucial role in neurotransmissions, BChE has no specific function apart from the detoxification of some drugs and secondary metabolites from plants. Thus, both AChE and BChE can serve as biochemical markers of various pathologies. Poisoning by nerve agents like sarin, soman, tabun, VX, novichok and overdosing by drugs used in some neurodegenerative disorders like Alzheimer\u00b4s disease and myasthenia gravis, as well as poisoning by organophosphorus pesticides are relevant to this issue. But it appears that changes in these enzymes take place in other processes including oxidative stress, inflammation, some types of cancer and genetically conditioned diseases. In this review, the cholinesterases are introduced, the mechanism of inhibitors action is explained and the relations between the cholinesterases and pathologies are explained.<\/jats:p><\/jats:sec>","DOI":"10.2174\/0929867326666190130161202","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T11:06:29Z","timestamp":1549019189000},"page":"2994-3011","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Diagnoses of Pathological States Based on Acetylcholinesterase and Butyrylcholinesterase"],"prefix":"10.2174","volume":"27","author":[{"given":"Miroslav","family":"Pohanka","sequence":"first","affiliation":[{"name":"Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 50001 Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1517\/13543776.2012.701619","volume":"22","author":"de los R\u00edos C.","year":"2012","unstructured":"de los R\u00edos C.; Cholinesterase inhibitors: a patent review (2007 - 2011). Expert Opin Ther Pat 2012,22(8),853-869","journal-title":"Expert Opin Ther Pat"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s40266-015-0273-x","volume":"32","author":"Deardorff W.J.","year":"2015","unstructured":"Deardorff W.J.; Feen E.; Grossberg G.T.; The use of cholinesterase inhibitors across all stages of alzheimer\u2019s disease. Drugs Aging 2015,32(7),537-547","journal-title":"Drugs Aging"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1517\/17425247.2011.561311","volume":"8","author":"Di Stefano A.","year":"2011","unstructured":"Di Stefano A.; Iannitelli A.; Laserra S.; Sozio P.; Drug delivery strategies for Alzheimer\u2019s disease treatment. Expert Opin Drug Deliv 2011,8(5),581-603","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.clinthera.2015.05.510","volume":"37","author":"Ehret M.J.","year":"2015","unstructured":"Ehret M.J.; Chamberlin K.W.; Current practices in the treatment of alzheimer disease: where is the evidence after the phase III Trials? Clin Ther 2015,37(8),1604-1616","journal-title":"Clin Ther"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1345\/aph.18211","volume":"33","author":"Krall W.J.","year":"1999","unstructured":"Krall W.J.; Sramek J.J.; Cutler N.R.; Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease. Ann Pharmacother 1999,33(4),441-450","journal-title":"Ann Pharmacother"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1517\/13543776.2012.701620","volume":"22","author":"Pohanka M.","year":"2012","unstructured":"Pohanka M.; Acetylcholinesterase inhibitors: a patent review (2008 - present). Expert Opin Ther Pat 2012,22(8),871-886","journal-title":"Expert Opin Ther Pat"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.5507\/bp.2011.036","volume":"155","author":"Pohanka M.","year":"2011","unstructured":"Pohanka M.; Cholinesterases, a target of pharmacology and toxicology. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2011,155(3),219-229","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/10807039991289554","volume":"5","author":"Young R.A.","year":"1999","unstructured":"Young R.A.; Opresko D.M.; Watson A.P.; Ross R.H.; King J.; Choudhury H.; Deriving toxicity values for organophosphate nerve agents: A position paper in support of the procedures and rationale for deriving oral RfDs for chemical warfare nerve agents. Hum Ecol Risk Assess 1999,5(3),589-634","journal-title":"Hum Ecol Risk Assess"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.toxlet.2009.07.025","volume":"190","author":"Jokanovi\u0107 M.","year":"2009","unstructured":"Jokanovi\u0107 M.; Medical treatment of acute poisoning with organophosphorus and carbamate pesticides. Toxicol Lett 2009,190(2),107-115","journal-title":"Toxicol Lett"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jns.2006.06.008","volume":"249","author":"Cannard K.","year":"2006","unstructured":"Cannard K.; The acute treatment of nerve agent exposure. J Neurol Sci 2006,249(1),86-94","journal-title":"J Neurol Sci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.bcp.2018.01.044","volume":"153","author":"Pope C.N.","year":"2018","unstructured":"Pope C.N.; Brimijoin S.; Cholinesterases and the fine line between poison and remedy. Biochem Pharmacol 2018,153(18),205-216","journal-title":"Biochem Pharmacol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.2174\/1389557517666170120153930","volume":"17","author":"Thapa S.","year":"2017","unstructured":"Thapa S.; Lv M.; Xu H.; Acetylcholinesterase: a primary target for drugs and insecticides. Mini Rev Med Chem 2017,17(17),1665-1676","journal-title":"Mini Rev Med Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF01738910","volume":"189","author":"Loewi O.","year":"1921","unstructured":"Loewi O.; Uber humorale ubertragbarkeit der Hernervenwirkung. I Mitt. Pflugers Arch 1921,189,239-242","journal-title":"Pflugers Arch"},{"key":"ref=14","first-page":"17","volume":"10","author":"Sheng Y.","year":"2018","unstructured":"Sheng Y.; Zhu L.; The crosstalk between autonomic nervous system and blood vessels. Int J Physiol Pathophysiol Pharmacol 2018,10(1),17-28","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ncl.2018.01.009","volume":"36","author":"Nishimune H.","year":"2018","unstructured":"Nishimune H.; Shigemoto K.; Practical anatomy of the neuromuscular junction in health and disease. Neurol Clin 2018,36(2),231-240","journal-title":"Neurol Clin"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.bbr.2009.12.046","volume":"221","author":"Woolf N.J.","year":"2011","unstructured":"Woolf N.J.; Butcher L.L.; Cholinergic systems mediate action from movement to higher consciousness. Behav Brain Res 2011,221(2),488-498","journal-title":"Behav Brain Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1113\/JP270561","volume":"594","author":"Hepple R.T.","year":"2016","unstructured":"Hepple R.T.; Rice C.L.; Innervation and neuromuscular control in ageing skeletal muscle. J Physiol 2016,594(8),1965-1978","journal-title":"J Physiol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/nyas.13507","volume":"1412","author":"Plomp J.J.","year":"2018","unstructured":"Plomp J.J.; Huijbers M.G.M.; Verschuuren J.J.G.M.; Neuromuscular synapse electrophysiology in myasthenia gravis animal models. Ann N Y Acad Sci 2018,1412(1),146-153","journal-title":"Ann N Y Acad Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"9809","DOI":"10.3390\/ijms15069809","volume":"15","author":"Pohanka M.","year":"2014","unstructured":"Pohanka M.; Inhibitors of acetylcholinesterase and butyrylcholinesterase meet immunity. Int J Mol Sci 2014,15(6),9809-9825","journal-title":"Int J Mol Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.resp.2013.02.002","volume":"187","author":"Tonhajzerova I.","year":"2013","unstructured":"Tonhajzerova I.; Mokra D.; Visnovcova Z.; Vagal function indexed by respiratory sinus arrhythmia and cholinergic anti-inflammatory pathway. Respir Physiol Neurobiol 2013,187(1),78-81","journal-title":"Respir Physiol Neurobiol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1365-2796.2009.02098.x","volume":"265","author":"Rosas-Ballina M.","year":"2009","unstructured":"Rosas-Ballina M.; Tracey K.J.; Cholinergic control of inflammation. J Intern Med 2009,265(6),663-679","journal-title":"J Intern Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.3390\/ijms13022219","volume":"13","author":"Pohanka M.","year":"2012","unstructured":"Pohanka M.; Alpha7 nicotinic acetylcholine receptor is a target in pharmacology and toxicology. Int J Mol Sci 2012,13(2),2219-2238","journal-title":"Int J Mol Sci"},{"key":"ref=23","doi-asserted-by":"publisher","DOI":"10.4081\/ejh.2011.e37","volume":"55","author":"Dorko F.","year":"2011","unstructured":"Dorko F.; Danko J.; Fle\u0161\u00e1rov\u00e1 S.; Boro\u0161 E.; Sobekov\u00e1 A.; Effect of pesticide bendiocarbamate on distribution of acetylcholine- and butyrylcholine-positive nerves in rabbit\u2019s thymus. Eur J Histochem 2011,55(4)","journal-title":"Eur J Histochem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/ar.20856","volume":"292","author":"Murabayashi H.","year":"2009","unstructured":"Murabayashi H.; Kuramoto H.; Ishikawa K.; Iwamoto J.; Miyakawa K.; Tanaka K.; Sekikawa M.; Sasaki M.; Kitamura N.; Oomori Y.; Acetylcholinesterase activity, choline acetyltransferase and vesicular acetylcholine transporter immunoreactivities in the rat adrenal gland during postnatal development. Anat Rec (Hoboken) 2009,292(3),371-380","journal-title":"Anat Rec (Hoboken)"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.2741\/1390","volume":"9","author":"Kawashima K.","year":"2004","unstructured":"Kawashima K.; Fujii T.; Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Front Biosci 2004,9,2063-2085","journal-title":"Front Biosci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1385\/CBB:45:1:111","volume":"45","author":"Snyder D.A.","year":"2006","unstructured":"Snyder D.A.; Kelly M.L.; Woodbury D.J.; SNARE complex regulation by phosphorylation. Cell Biochem Biophys 2006,45(1),111-123","journal-title":"Cell Biochem Biophys"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0092-8674(95)90239-2","volume":"83","author":"McMahon H.T.","year":"1995","unstructured":"McMahon H.T.; Missler M.; Li C.; S\u00fcdhof T.C.; Complexins: cytosolic proteins that regulate SNAP receptor function. Cell 1995,83(1),111-119","journal-title":"Cell"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1385\/JMN:30:1:215","volume":"30","author":"Searl T.J.","year":"2006","unstructured":"Searl T.J.; Silinsky E.M.; Modulation of calcium-dependent and -independent acetylcholine release from motor nerve endings. J Mol Neurosci 2006,30(1-2),215-218","journal-title":"J Mol Neurosci"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1002\/cne.23296","volume":"521","author":"Sharrad D.F.","year":"2013","unstructured":"Sharrad D.F.; Gai W.P.; Brookes S.J.; Selective coexpression of synaptic proteins, \u03b1-synuclein, cysteine string protein-\u03b1, synaptophysin, synaptotagmin-1, and synaptobrevin-2 in vesicular acetylcholine transporter-immunoreactive axons in the guinea pig ileum. J Comp Neurol 2013,521(11),2523-2537","journal-title":"J Comp Neurol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/S0165-6147(03)00195-0","volume":"24","author":"Wess J.","year":"2003","unstructured":"Wess J.; Novel insights into muscarinic acetylcholine receptor function using gene targeting technology. Trends Pharmacol Sci 2003,24(8),414-420","journal-title":"Trends Pharmacol Sci"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/aps.2013.181","volume":"35","author":"Wu J.","year":"2014","unstructured":"Wu J.; Gao M.; Taylor D.H.; Neuronal nicotinic acetylcholine receptors are important targets for alcohol reward and dependence. Acta Pharmacol Sin 2014,35(3),311-315","journal-title":"Acta Pharmacol Sin"},{"key":"ref=32","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2017.0174","volume":"373","author":"Changeux J.P.","year":"2018","unstructured":"Changeux J.P.; The nicotinic acetylcholine receptor: a typical \u2018allosteric machine\u2019. Philos Trans R Soc Lond B Biol Sci 2018,373(1749)","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/jphp.12919","volume":"70","author":"Verma S.","year":"2018","unstructured":"Verma S.; Kumar A.; Tripathi T.; Kumar A.; Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer\u2019s disease therapy. J Pharm Pharmacol 2018,70(8),985-993","journal-title":"J Pharm Pharmacol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1023\/A:1022873323561","volume":"28","author":"Dobransky T.","year":"2003","unstructured":"Dobransky T.; Rylett R.J.; Functional regulation of choline acetyltransferase by phosphorylation. Neurochem Res 2003,28(3-4),537-542","journal-title":"Neurochem Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1471-4159.2005.03367.x","volume":"95","author":"Dobransky T.","year":"2005","unstructured":"Dobransky T.; Rylett R.J.; A model for dynamic regulation of choline acetyltransferase by phosphorylation. J Neurochem 2005,95(2),305-313","journal-title":"J Neurochem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/B978-0-12-800223-0.00003-7","volume":"73","author":"Anne C.","year":"2014","unstructured":"Anne C.; Gasnier B.; Vesicular neurotransmitter transporters: mechanistic aspects. Curr Top Membr 2014,73,149-174","journal-title":"Curr Top Membr"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.mam.2012.07.005","volume":"34","author":"Lawal H.O.","year":"2013","unstructured":"Lawal H.O.; Krantz D.E.; SLC18: Vesicular neurotransmitter transporters for monoamines and acetylcholine. Mol Aspects Med 2013,34(2-3),360-372","journal-title":"Mol Aspects Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cbi.2016.02.013","volume":"259","author":"Brimijoin S.","year":"2016","unstructured":"Brimijoin S.; Chen V.P.; Pang Y.P.; Geng L.; Gao Y.; Physiological roles for butyrylcholinesterase: A BChE-ghrelin axis. Chem Biol Interact 2016,259(Pt B),271-275","journal-title":"Chem Biol Interact"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/BF01120311","volume":"4","author":"Schuman R.F.","year":"1984","unstructured":"Schuman R.F.; Brimfield A.A.; Hunter K.W.; A micro-method for the detection of butyrylcholinesterase secreted by hepatocytes in vitro. Biosci Rep 1984,4(2),149-154","journal-title":"Biosci Rep"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/jcla.1860080411","volume":"8","author":"Kutty K.M.","year":"1994","unstructured":"Kutty K.M.; Payne R.H.; Serum pseudocholinesterase and very-low-density lipoprotein metabolism. J Clin Lab Anal 1994,8(4),247-250","journal-title":"J Clin Lab Anal"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1399-6576.1988.tb02727.x","volume":"32","author":"Ostergaard D.","year":"1988","unstructured":"Ostergaard D.; Viby-Mogensen J.; Hanel H.K.; Skovgaard L.T.; Half-life of plasma cholinesterase. Acta Anaesthesiol Scand 1988,32(3),266-269","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1021\/ja020850+","volume":"125","author":"Zhan C.G.","year":"2003","unstructured":"Zhan C.G.; Zheng F.; Landry D.W.; Fundamental reaction mechanism for cocaine hydrolysis in human butyrylcholinesterase. J Am Chem Soc 2003,125(9),2462-2474","journal-title":"J Am Chem Soc"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/(SICI)1099-081X(199807)19:5<309:AID-BDD108>3.0.CO;2-9","volume":"19","author":"Browne S.P.","year":"1998","unstructured":"Browne S.P.; Slaughter E.A.; Couch R.A.; Rudnic E.M.; McLean A.M.; The influence of plasma butyrylcholinesterase concentration on the in vitro hydrolysis of cocaine in human plasma. Biopharm Drug Dispos 1998,19(5),309-314","journal-title":"Biopharm Drug Dispos"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"6467","DOI":"10.1021\/bi400709v","volume":"52","author":"Qiao Y.","year":"2013","unstructured":"Qiao Y.; Han K.; Zhan C.G.; Fundamental reaction pathway and free energy profile for butyrylcholinesterase-catalyzed hydrolysis of heroin. Biochemistry 2013,52(37),6467-6479","journal-title":"Biochemistry"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1042\/BJ20140360","volume":"460","author":"Hou S.","year":"2014","unstructured":"Hou S.; Zhan M.; Zheng X.; Zhan C.G.; Zheng F.; Kinetic characterization of human butyrylcholinesterase mutants for the hydrolysis of cocaethylene. Biochem J 2014,460(3),447-457","journal-title":"Biochem J"},{"key":"ref=46","first-page":"183","volume":"28","author":"Nana A.","year":"1977","unstructured":"Nana A.; Cardan E.; Cucuianu M.; Pseudocholinesterase changes in anesthesia using pancuronium. Acta Anaesthesiol Belg 1977,28(3),183-187","journal-title":"Acta Anaesthesiol Belg"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.chroma.2007.02.024","volume":"1154","author":"Yuan J.","year":"2007","unstructured":"Yuan J.; Yin J.; Wang E.; Characterization of procaine metabolism as probe for the butyrylcholinesterase enzyme investigation by simultaneous determination of procaine and its metabolite using capillary electrophoresis with electrochemiluminescence detection. J Chromatogr A 2007,1154(1-2),368-372","journal-title":"J Chromatogr A"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/BF03019772","volume":"48","author":"Monedero P.","year":"2001","unstructured":"Monedero P.; Hess P.; High epidural block with chloroprocaine in a parturient with low pseudocholinesterase activity. Can J Anaesth 2001,48(3),318-319","journal-title":"Can J Anaesth"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1023\/A:1026323124831","volume":"136","author":"Galenko-Yaroshevskii A.P.","year":"2003","unstructured":"Galenko-Yaroshevskii A.P.; Derlugov L.P.; Ponomarev V.V.; Dukhanin A.S.; Pharmacokinetics and pharmacodynamics of a new local anesthetic agent. Bull Exp Biol Med 2003,136(2),170-173","journal-title":"Bull Exp Biol Med"},{"key":"ref=50","first-page":"37","volume":"7","author":"Dubbels R.","year":"1983","unstructured":"Dubbels R.; Schloot W.; Studies on the metabolism of benoxinate by human pseudocholinesterase. Metab Pediatr Syst Ophthalmol 1983,7(1),37-43","journal-title":"Metab Pediatr Syst Ophthalmol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0167-4838(98)00104-6","volume":"1387","author":"Masson P.","year":"1998","unstructured":"Masson P.; Froment M.T.; Fortier P.L.; Visicchio J.E.; Bartels C.F.; Lockridge O.; Butyrylcholinesterase-catalysed hydrolysis of aspirin, a negatively charged ester, and aspirin-related neutral esters. Biochim Biophys Acta 1998,1387(1-2),41-52","journal-title":"Biochim Biophys Acta"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"11940","DOI":"10.1074\/jbc.M112.427674","volume":"288","author":"Zhou G.","year":"2013","unstructured":"Zhou G.; Marathe G.K.; Hartiala J.; Hazen S.L.; Allayee H.; Tang W.H.; McIntyre T.M.; Aspirin hydrolysis in plasma is a variable function of butyrylcholinesterase and platelet-activating factor acetylhydrolase 1b2 (PAFAH1b2). J Biol Chem 2013,288(17),11940-11948","journal-title":"J Biol Chem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1124\/dmd.109.031724","volume":"38","author":"Albert\u00ed J.","year":"2010","unstructured":"Albert\u00ed J.; Martinet A.; Sentellas S.; Salv\u00e0 M.; Identification of the human enzymes responsible for the enzymatic hydrolysis of aclidinium bromide. Drug Metab Dispos 2010,38(7),1202-1210","journal-title":"Drug Metab Dispos"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/bja\/aev228","volume":"115","author":"Ammundsen H.B.","year":"2015","unstructured":"Ammundsen H.B.; S\u00f8rensen M.K.; G\u00e4tke M.R.; Succinylcholine resistance. Br J Anaesth 2015,115(6),818-821","journal-title":"Br J Anaesth"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/FPC.0000000000000221","volume":"26","author":"Wichmann S.","year":"2016","unstructured":"Wichmann S.; F\u00e6rk G.; Bundgaard J.R.; G\u00e4tke M.R.; Patients with prolonged effect of succinylcholine or mivacurium had novel mutations in the butyrylcholinesterase gene. Pharmacogenet Genomics 2016,26(7),351-356","journal-title":"Pharmacogenet Genomics"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/FPC.0b013e3282f06646","volume":"17","author":"G\u00e4tke M.R.","year":"2007","unstructured":"G\u00e4tke M.R.; Bundgaard J.R.; Viby-Mogensen J.; Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia. Pharmacogenet Genomics 2007,17(11),995-999","journal-title":"Pharmacogenet Genomics"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cbi.2017.02.004","volume":"266","author":"Dafferner A.J.","year":"2017","unstructured":"Dafferner A.J.; Lushchekina S.; Masson P.; Xiao G.; Schopfer L.M.; Lockridge O.; Characterization of butyrylcholinesterase in bovine serum. Chem Biol Interact 2017,266,17-27","journal-title":"Chem Biol Interact"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"20774","DOI":"10.1074\/jbc.M115.653741","volume":"290","author":"Ruiz C.A.","year":"2015","unstructured":"Ruiz C.A.; Rossi S.G.; Rotundo R.L.; Rescue and stabilization of acetylcholinesterase in skeletal muscle by N-terminal peptides derived from the noncatalytic subunits. J Biol Chem 2015,290(34),20774-20781","journal-title":"J Biol Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2147\/IJN.S41591","volume":"8","author":"Jiang S.","year":"2013","unstructured":"Jiang S.; Wang X.; Xi R.; Zhang Y.; Research on the regulation of the spatial structure of acetylcholinesterase tetramer with high efficiency by AFM. Int J Nanomedicine 2013,8,1095-1102","journal-title":"Int J Nanomedicine"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1529\/biophysj.107.117879","volume":"94","author":"Gorfe A.A.","year":"2008","unstructured":"Gorfe A.A.; Chang C.E.; Ivanov I.; McCammon J.A.; Dynamics of the acetylcholinesterase tetramer. Biophys J 2008,94(4),1144-1154","journal-title":"Biophys J"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/jnc.14448","volume":"146","author":"Xu M.L.","year":"2018","unstructured":"Xu M.L.; Luk W.K.W.; Bi C.W.C.; Liu E.Y.L.; Wu K.Q.Y.; Yao P.; Dong T.T.X.; Tsim K.W.K.; Erythropoietin regulates the expression of dimeric form of acetylcholinesterase during differentiation of erythroblast. J Neurochem 2018,146(4),390-402","journal-title":"J Neurochem"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"17640","DOI":"10.1016\/S0021-9258(19)37091-7","volume":"267","author":"Shafferman A.","year":"1992","unstructured":"Shafferman A.; Kronman C.; Flashner Y.; Leitner M.; Grosfeld H.; Ordentlich A.; Gozes Y.; Cohen S.; Ariel N.; Barak D.; Harel M.; Silman I.; Sussman J.L.; Velan B.; Mutagenesis of human acetylcholinesterase. Identification of residues involved in catalytic activity and in polypeptide folding. J Biol Chem 1992,267(25),17640-17648","journal-title":"J Biol Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00439-013-1391-3","volume":"133","author":"Arredondo J.","year":"2014","unstructured":"Arredondo J.; Lara M.; Ng F.; Gochez D.A.; Lee D.C.; Logia S.P.; Nguyen J.; Maselli R.A.; COOH-terminal collagen Q (COLQ) mutants causing human deficiency of endplate acetylcholinesterase impair the interaction of ColQ with proteins of the basal lamina. Hum Genet 2014,133(5),599-616","journal-title":"Hum Genet"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cbi.2012.08.020","volume":"203","author":"Ohno K.","year":"2013","unstructured":"Ohno K.; Ito M.; Kawakami Y.; Krejci E.; Engel A.G.; Specific binding of collagen Q to the neuromuscular junction is exploited to cure congenital myasthenia and to explore bases of myasthenia gravis. Chem Biol Interact 2013,203(1),335-340","journal-title":"Chem Biol Interact"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1523\/JNEUROSCI.4374-09.2010","volume":"30","author":"Sigoillot S.M.","year":"2010","unstructured":"Sigoillot S.M.; Bourgeois F.; Lambergeon M.; Strochlic L.; Legay C.; ColQ controls postsynaptic differentiation at the neuromuscular junction. J Neurosci 2010,30(1),13-23","journal-title":"J Neurosci"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"13233","DOI":"10.1523\/JNEUROSCI.2935-14.2015","volume":"35","author":"Tsui C.C.","year":"2015","unstructured":"Tsui C.C.; Gabreski N.A.; Hein S.J.; Pierchala B.A.; Lipid rafts are physiologic membrane microdomains necessary for the morphogenic and developmental functions of glial cell line-derived neurotrophic factor in vivo. J Neurosci 2015,35(38),13233-13243","journal-title":"J Neurosci"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ibmb.2010.11.005","volume":"41","author":"Kakani E.G.","year":"2011","unstructured":"Kakani E.G.; Bon S.; Massouli\u00e9 J.; Mathiopoulos K.D.; Altered GPI modification of insect AChE improves tolerance to organophosphate insecticides. Insect Biochem Mol Biol 2011,41(3),150-158","journal-title":"Insect Biochem Mol Biol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0167-4838(99)00079-5","volume":"1431","author":"Bucht G.","year":"1999","unstructured":"Bucht G.; Wikstr\u00f6m P.; Hjalmarsson K.; Optimising the signal peptide for glycosyl phosphatidylinositol modification of human acetylcholinesterase using mutational analysis and peptide-quantitative structure-activity relationships. Biochim Biophys Acta 1999,1431(2),471-482","journal-title":"Biochim Biophys Acta"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00249-004-0417-0","volume":"33","author":"Arsov Z.","year":"2004","unstructured":"Arsov Z.; Schara M.; Zorko M.; Strancar J.; The membrane lateral domain approach in the studies of lipid-protein interaction of GPI-anchored bovine erythrocyte acetylcholinesterase. Eur Biophys J 2004,33(8),715-725","journal-title":"Eur Biophys J"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"27265","DOI":"10.1074\/jbc.M110.113647","volume":"285","author":"Chen V.P.","year":"2010","unstructured":"Chen V.P.; Xie H.Q.; Chan W.K.; Leung K.W.; Chan G.K.; Choi R.C.; Bon S.; Massouli\u00e9 J.; Tsim K.W.; The PRiMA-linked cholinesterase tetramers are assembled from homodimers: hybrid molecules composed of acetylcholinesterase and butyrylcholinesterase dimers are up-regulated during development of chicken brain. J Biol Chem 2010,285(35),27265-27278","journal-title":"J Biol Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"32948","DOI":"10.1074\/jbc.M111.261248","volume":"286","author":"Chen V.P.","year":"2011","unstructured":"Chen V.P.; Choi R.C.; Chan W.K.; Leung K.W.; Guo A.J.; Chan G.K.; Luk W.K.; Tsim K.W.; The assembly of proline-rich membrane anchor (PRiMA)-linked acetylcholinesterase enzyme: glycosylation is required for enzymatic activity but not for oligomerization. J Biol Chem 2011,286(38),32948-32961","journal-title":"J Biol Chem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.cbi.2012.09.019","volume":"203","author":"Hicks D.A.","year":"2013","unstructured":"Hicks D.A.; Makova N.Z.; Nalivaeva N.N.; Turner A.J.; Characterisation of acetylcholinesterase release from neuronal cells. Chem Biol Interact 2013,203(1),302-308","journal-title":"Chem Biol Interact"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.3233\/JRS-150695","volume":"27","author":"Petrov K.","year":"2015","unstructured":"Petrov K.; Macrocyclic derivatives of 6-methyluracil: New ligands of the peripheral anionic site of acetylcholinesterase. Int J Risk Saf Med 2015,27(1)(Suppl. 1),S72-S73","journal-title":"Int J Risk Saf Med"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.bbrc.2010.12.084","volume":"404","author":"Nawaz S.A.","year":"2011","unstructured":"Nawaz S.A.; Ayaz M.; Brandt W.; Wessjohann L.A.; Westermann B.; Cation-\u03c0 and \u03c0-\u03c0 stacking interactions allow selective inhibition of butyrylcholinesterase by modified quinine and cinchonidine alkaloids. Biochem Biophys Res Commun 2011,404(4),935-940","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bioorg.2018.05.006","volume":"79","author":"Kilic B.","year":"2018","unstructured":"Kilic B.; Gulcan H.O.; Aksakal F.; Ercetin T.; Oruklu N.; Umit Bagriacik E.; Dogruer D.S.; Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase. Bioorg Chem 2018,79,235-249","journal-title":"Bioorg Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/cbdd.13111","volume":"91","author":"Skibi\u0144ski R.","year":"2018","unstructured":"Skibi\u0144ski R.; Czarnecka K.; Girek M.; Bilichowski I.; Chufarova N.; Mikiciuk-Olasik E.; Szyma\u0144ski P.; Novel tetrahydroacridine derivatives with iodobenzoic acid moiety as multifunctional acetylcholinesterase inhibitors. Chem Biol Drug Des 2018,91(2),505-518","journal-title":"Chem Biol Drug Des"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1432-1033.1996.00036.x","volume":"235","author":"Masson P.","year":"1996","unstructured":"Masson P.; Froment M.T.; Bartels C.F.; Lockridge O.; Asp7O in the peripheral anionic site of human butyrylcholinesterase. Eur J Biochem 1996,235(1-2),36-48","journal-title":"Eur J Biochem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2174\/138161206775193127","volume":"12","author":"Johnson G.","year":"2006","unstructured":"Johnson G.; Moore S.W.; The peripheral anionic site of acetylcholinesterase: structure, functions and potential role in rational drug design. Curr Pharm Des 2006,12(2),217-225","journal-title":"Curr Pharm Des"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1016\/S0021-9258(17)37371-4","volume":"269","author":"Barak D.","year":"1994","unstructured":"Barak D.; Kronman C.; Ordentlich A.; Ariel N.; Bromberg A.; Marcus D.; Lazar A.; Velan B.; Shafferman A.; Acetylcholinesterase peripheral anionic site degeneracy conferred by amino acid arrays sharing a common core. J Biol Chem 1994,269(9),6296-6305","journal-title":"J Biol Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"14642","DOI":"10.1021\/bi971425+","volume":"36","author":"Saxena A.","year":"1997","unstructured":"Saxena A.; Redman A.M.; Jiang X.; Lockridge O.; Doctor B.P.; Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase. Biochemistry 1997,36(48),14642-14651","journal-title":"Biochemistry"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.33786\/JCPR.2015.v05i04.006","volume":"5","author":"Ranjan A.","year":"2015","unstructured":"Ranjan A.; Kumar A.; Gulati K.; Thakur S.; Jindal T.; Role of aromatic amino acids in stabilizing organophosphate and human acetylcholinesterase Complex. J Curr Pharm Res 2015,5(4),1632-1639","journal-title":"J Curr Pharm Res"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/1570159X11311030006","volume":"11","author":"Colovi\u0107 M.B.","year":"2013","unstructured":"Colovi\u0107 M.B.; Krsti\u0107 D.Z.; Lazarevi\u0107-Pa\u0161ti T.D.; Bond\u017ei\u0107 A.M.; Vasi\u0107 V.M.; Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol 2013,11(3),315-335","journal-title":"Curr Neuropharmacol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"10572","DOI":"10.1021\/ja020243m","volume":"124","author":"Zhang Y.","year":"2002","unstructured":"Zhang Y.; Kua J.; McCammon J.A.; Role of the catalytic triad and oxyanion hole in acetylcholinesterase catalysis: an ab initio QM\/MM study. J Am Chem Soc 2002,124(35),10572-10577","journal-title":"J Am Chem Soc"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2174\/0929867003375281","volume":"7","author":"Bai D.L.","year":"2000","unstructured":"Bai D.L.; Tang X.C.; He X.C.; Huperzine A.; Huperzine A, a potential therapeutic agent for treatment of Alzheimer\u2019s disease. Curr Med Chem 2000,7(3),355-374","journal-title":"Curr Med Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0306-4522(01)00206-8","volume":"105","author":"Zhang J.M.","year":"2001","unstructured":"Zhang J.M.; Hu G.Y.; Huperzine A.; Huperzine A, a nootropic alkaloid, inhibits N-methyl-D-aspartate-induced current in rat dissociated hippocampal neurons. Neuroscience 2001,105(3),663-669","journal-title":"Neuroscience"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pharmthera.2011.12.002","volume":"134","author":"Tayeb H.O.","year":"2012","unstructured":"Tayeb H.O.; Yang H.D.; Price B.H.; Tarazi F.I.; Pharmacotherapies for Alzheimer\u2019s disease: beyond cholinesterase inhibitors. Pharmacol Ther 2012,134(1),8-25","journal-title":"Pharmacol Ther"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1517\/14656566.2013.760543","volume":"14","author":"Cheewakriengkrai L.","year":"2013","unstructured":"Cheewakriengkrai L.; Gauthier S.; A 10-year perspective on donepezil. Expert Opin Pharmacother 2013,14(3),331-338","journal-title":"Expert Opin Pharmacother"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/1874104501711010024","volume":"11","author":"Teponnou G.A.K.","year":"2017","unstructured":"Teponnou G.A.K.; Joubert J.; Malan S.F.; Tacrine, trolox and tryptoline as lead compounds for the design and synthesis of multi-target agents for alzheimer\u2019s disease therapy. Open Med Chem J 2017,11,24-37","journal-title":"Open Med Chem J"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.etap.2014.01.001","volume":"37","author":"Pohanka M.","year":"2014","unstructured":"Pohanka M.; Copper, aluminum, iron and calcium inhibit human acetylcholinesterase in vitro. Environ Toxicol Pharmacol 2014,37(1),455-459","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"9873","DOI":"10.3390\/ijms14059873","volume":"14","author":"Pohanka M.","year":"2013","unstructured":"Pohanka M.; Dobes P.; Caffeine inhibits acetylcholinesterase, but not butyrylcholinesterase. Int J Mol Sci 2013,14(5),9873-9882","journal-title":"Int J Mol Sci"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2174\/1389557514666140529223436","volume":"14","author":"Pohanka M.","year":"2014","unstructured":"Pohanka M.; The effects of caffeine on the cholinergic system. Mini Rev Med Chem 2014,14(6),543-549","journal-title":"Mini Rev Med Chem"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.tox.2004.07.009","volume":"206","author":"Cometa M.F.","year":"2005","unstructured":"Cometa M.F.; Lorenzini P.; Fortuna S.; Volpe M.T.; Meneguz A.; Palmery M.; In vitro inhibitory effect of aflatoxin B1 on acetylcholinesterase activity in mouse brain. Toxicology 2005,206(1),125-135","journal-title":"Toxicology"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1021\/ac061819j","volume":"79","author":"Arduini F.","year":"2007","unstructured":"Arduini F.; Errico I.; Amine A.; Micheli L.; Palleschi G.; Moscone D.; Enzymatic spectrophotometric method for aflatoxin B detection based on acetylcholinesterase inhibition. Anal Chem 2007,79(9),3409-3415","journal-title":"Anal Chem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/00000542-200008000-00031","volume":"93","author":"McGehee D.S.","year":"2000","unstructured":"McGehee D.S.; Krasowski M.D.; Fung D.L.; Wilson B.; Gronert G.A.; Moss J.; Cholinesterase inhibition by potato glycoalkaloids slows mivacurium metabolism. Anesthesiology 2000,93(2),510-519","journal-title":"Anesthesiology"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1527-3458.2002.tb00221.x","volume":"8","author":"Lilienfeld S.","year":"2002","unstructured":"Lilienfeld S.; Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer\u2019s disease. CNS Drug Rev 2002,8(2),159-176","journal-title":"CNS Drug Rev"},{"key":"ref=96","first-page":"27","volume":"14","author":"Mashkovsky M.D.","year":"1951","unstructured":"Mashkovsky M.D.; Kruglikova-Lvova R.P.; On the pharmacology of the new alkaloid galantamine. Farmakologiea Toxicologia (Moscow) 1951,14,27-30","journal-title":"Farmakologiea Toxicologia (Moscow)"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"40180","DOI":"10.1074\/jbc.M110.142356","volume":"285","author":"Takata K.","year":"2010","unstructured":"Takata K.; Kitamura Y.; Saeki M.; Terada M.; Kagitani S.; Kitamura R.; Fujikawa Y.; Maelicke A.; Tomimoto H.; Taniguchi T.; Shimohama S.; Galantamine-induced amyloid-beta clearance mediated via stimulation of microglial nicotinic acetylcholine receptors. J Biol Chem 2010,285(51),40180-40191","journal-title":"J Biol Chem"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2165\/00023210-199707020-00001","volume":"7","author":"Rainer M.","year":"1997","unstructured":"Rainer M.; Galanthamine in Alzheimer\u2019s disease : a new alternative to tacrine? CNS Drugs 1997,7(2),89-97","journal-title":"CNS Drugs"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1021\/jm040787u","volume":"47","author":"Cavalli A.","year":"2004","unstructured":"Cavalli A.; Bottegoni G.; Raco C.; De Vivo M.; Recanatini M.; A computational study of the binding of propidium to the peripheral anionic site of human acetylcholinesterase. J Med Chem 2004,47(16),3991-3999","journal-title":"J Med Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cbi.2006.05.013","volume":"162","author":"Mazzanti C.M.","year":"2006","unstructured":"Mazzanti C.M.; Spanevello R.M.; Obregon A.; Pereira L.B.; Streher C.A.; Ahmed M.; Mazzanti A.; Gra\u00e7a D.L.; Morsch V.M.; Schetinger M.R.; Ethidium bromide inhibits rat brain acetylcholinesterase activity in vitro. Chem Biol Interact 2006,162(2),121-127","journal-title":"Chem Biol Interact"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.3233\/JRS-150694","volume":"27","author":"Zueva I.V.","year":"2015","unstructured":"Zueva I.V.; Semenov V.E.; Mukhamedyarov M.A.; Lushchekina S.V.; Kharlamova A.D.; Petukhova E.O.; Mikhailov A.S.; Podyachev S.N.; Saifina L.F.; Petrov K.A.; Minnekhanova O.A.; Zobov V.V.; Nikolsky E.E.; Masson P.; Reznik V.S.; 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer\u2019s disease. Int J Risk Saf Med 2015,27(1)(Suppl. 1),S69-S71","journal-title":"Int J Risk Saf Med"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2174\/1381612820666141014124319","volume":"21","author":"Martini F.","year":"2015","unstructured":"Martini F.; Bruning C.A.; Soares S.M.; Nogueira C.W.; Zeni G.; Inhibitory effect of ebselen on cerebral acetylcholinesterase activity in vitro: kinetics and reversibility of inhibition. Curr Pharm Des 2015,21(7),920-924","journal-title":"Curr Pharm Des"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1080\/07391102.2015.1077345","volume":"34","author":"da Silva Gon\u00e7alves A.","year":"2016","unstructured":"da Silva Gon\u00e7alves A.; Fran\u00e7a T.C.; Vital de Oliveira O.; Computational studies of acetylcholinesterase complexed with fullerene derivatives: a new insight for Alzheimer disease treatment. J Biomol Struct Dyn 2016,34(6),1307-1316","journal-title":"J Biomol Struct Dyn"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/psc.2797","volume":"21","author":"Kafurke U.","year":"2015","unstructured":"Kafurke U.; Erijman A.; Aizner Y.; Shifman J.M.; Eichler J.; Synthetic peptides mimicking the binding site of human acetylcholinesterase for its inhibitor fasciculin 2. J Pept Sci 2015,21(9),723-730","journal-title":"J Pept Sci"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/protein\/gzp045","volume":"22","author":"Sharabi O.","year":"2009","unstructured":"Sharabi O.; Peleg Y.; Mashiach E.; Vardy E.; Ashani Y.; Silman I.; Sussman J.L.; Shifman J.M.; Design, expression and characterization of mutants of fasciculin optimized for interaction with its target, acetylcholinesterase. Protein Eng Des Sel 2009,22(10),641-648","journal-title":"Protein Eng Des Sel"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxicon.2018.06.080","volume":"152","author":"Vanzolini K.L.","year":"2018","unstructured":"Vanzolini K.L.; Ainsworth S.; Bruyneel B.; Herzig V.; Seraus M.G.L.; Somsen G.W.; Casewell N.R.; Cass Q.B.; Kool J.; Rapid ligand fishing for identification of acetylcholinesterase-binding peptides in snake venom reveals new properties of dendrotoxins. Toxicon 2018,152,1-8","journal-title":"Toxicon"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1002\/etc.5620211109","volume":"21","author":"Sanchez-Hernandez J.C.","year":"2002","unstructured":"Sanchez-Hernandez J.C.; Sanchez B.M.; Lizard cholinesterases as biomarkers of pesticide exposure: enzymological characterization. Environ Toxicol Chem 2002,21(11),2319-2325","journal-title":"Environ Toxicol Chem"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/annweh\/wxx084","volume":"62","author":"Keegan T.J.","year":"2017","unstructured":"Keegan T.J.; Carpenter L.M.; Brooks C.; Langdon T.; Venables K.M.; Sarin exposures in a cohort of british military participants in human experimental research at porton down 1945-1987. Ann Work Expo Health 2017,62(1),17-27","journal-title":"Ann Work Expo Health"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/10408444.2016.1220916","volume":"46","author":"Abou-Donia M.B.","year":"2016","unstructured":"Abou-Donia M.B.; Siracuse B.; Gupta N.; Sobel Sokol A.; Sarin (GB, O-isopropyl methylphosphonofluoridate) neurotoxicity: critical review. Crit Rev Toxicol 2016,46(10),845-875","journal-title":"Crit Rev Toxicol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.toxlet.2015.11.023","volume":"241","author":"Wright L.K.","year":"2016","unstructured":"Wright L.K.; Lee R.B.; Vincelli N.M.; Whalley C.E.; Lumley L.A.; Comparison of the lethal effects of chemical warfare nerve agents across multiple ages. Toxicol Lett 2016,241,167-174","journal-title":"Toxicol Lett"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1080\/15563650.2018.1469759","volume":"56","author":"Vale J.A.","year":"2018","unstructured":"Vale J.A.; Marrs T.C.; Maynard R.L.; Novichok: a murderous nerve agent attack in the UK. Clin Toxicol (Phila) 2018,56(11),1093-1097","journal-title":"Clin Toxicol (Phila)"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0022-474X(89)90039-8","volume":"25","author":"Al-Hakka Z.S.","year":"1989","unstructured":"Al-Hakka Z.S.; Al-Azzawi M.J.; Al-Adhamy B.W.; Khalil S.A.; Inhibitory action of phosphine on acetylcholinesterase of Ephestia cautella (Lepidoptera: Pyralidae). J Stored Prod Res 1989,25(3),171-174","journal-title":"J Stored Prod Res"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/089198870101400211","volume":"14","author":"Cummings J.L.","year":"2001","unstructured":"Cummings J.L.; Nadel A.; Masterman D.; Cyrus P.A.; Efficacy of metrifonate in improving the psychiatric and behavioral disturbances of patients with Alzheimer\u2019s disease. J Geriatr Psychiatry Neurol 2001,14(2),101-108","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3109\/15376516.2011.589089","volume":"21","author":"Pohanka M.","year":"2011","unstructured":"Pohanka M.; Novotny L.; Pikula J.; Metrifonate alters antioxidant levels and caspase activity in cerebral cortex of Wistar rats. Toxicol Mech Methods 2011,21(8),585-590","journal-title":"Toxicol Mech Methods"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2165\/00139709-200322030-00003","volume":"22","author":"Eyer F.","year":"2003","unstructured":"Eyer F.; Meischner V.; Kiderlen D.; Thiermann H.; Worek F.; Haberkorn M.; Felgenhauer N.; Zilker T.; Eyer P.; Human parathion poisoning. A toxicokinetic analysis. Toxicol Rev 2003,22(3),143-163","journal-title":"Toxicol Rev"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-4757-6429-1_2","volume":"163","author":"Nigg H.N.","year":"2000","unstructured":"Nigg H.N.; Knaak J.B.; Blood cholinesterases as human biomarkers of organophosphorus pesticide exposure. Rev Environ Contam Toxicol 2000,163,29-111","journal-title":"Rev Environ Contam Toxicol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s10565-013-9259-9","volume":"29","author":"Marrs T.C.","year":"2013","unstructured":"Marrs T.C.; Maynard R.L.; Neurotranmission systems as targets for toxicants: a review. Cell Biol Toxicol 2013,29(6),381-396","journal-title":"Cell Biol Toxicol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1021\/jm8002075","volume":"51","author":"Darvesh S.","year":"2008","unstructured":"Darvesh S.; Darvesh K.V.; McDonald R.S.; Mataija D.; Walsh R.; Mothana S.; Lockridge O.; Martin E.; Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase. J Med Chem 2008,51(14),4200-4212","journal-title":"J Med Chem"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1080\/14740338.2017.1351540","volume":"16","author":"Mohammad D.","year":"2017","unstructured":"Mohammad D.; Chan P.; Bradley J.; Lanct\u00f4t K.; Herrmann N.; Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation. Expert Opin Drug Saf 2017,16(9),1009-1019","journal-title":"Expert Opin Drug Saf"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.ecoenv.2011.07.015","volume":"74","author":"Chelinho S.","year":"2011","unstructured":"Chelinho S.; Dieter Sautter K.; Cachada A.; Abrantes I.; Brown G.; Costa Duarte A.; Sousa J.P.; Carbofuran effects in soil nematode communities: using trait and taxonomic based approaches. Ecotoxicol Environ Saf 2011,74(7),2002-2012","journal-title":"Ecotoxicol Environ Saf"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/0006-291X(92)90649-6","volume":"184","author":"Ashani Y.","year":"1992","unstructured":"Ashani Y.; Peggins J.O.; Doctor B.P.; Mechanism of inhibition of cholinesterases by huperzine A. Biochem Biophys Res Commun 1992,184(2),719-726","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cbi.2017.07.003","volume":"274","author":"Rosenberg Y.J.","year":"2017","unstructured":"Rosenberg Y.J.; Mao L.; Jiang X.; Lees J.; Zhang L.; Radic Z.; Taylor P.; Post-exposure treatment with the oxime RS194B rapidly reverses early and advanced symptoms in macaques exposed to sarin vapor. Chem Biol Interact 2017,274,50-57","journal-title":"Chem Biol Interact"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cbi.2016.07.004","volume":"259","author":"Chambers J.E.","year":"2016","unstructured":"Chambers J.E.; Chambers H.W.; Funck K.E.; Meek E.C.; Pringle R.B.; Ross M.K.; Efficacy of novel phenoxyalkyl pyridinium oximes as brain-penetrating reactivators of cholinesterase inhibited by surrogates of sarin and VX. ChemBiol Interact, 2016,259(Pt B),154-159","journal-title":"ChemBiol Interact,"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/nyas.13053","volume":"1374","author":"Chambers J.E.","year":"2016","unstructured":"Chambers J.E.; Meek E.C.; Chambers H.W.; Novel brain-penetrating oximes for reactivation of cholinesterase inhibited by sarin and VX surrogates. Ann N Y Acad Sci 2016,1374(1),52-58","journal-title":"Ann N Y Acad Sci"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fnmol.2018.00166","volume":"11","author":"Veszelka S.","year":"2018","unstructured":"Veszelka S.; T\u00f3th A.; Walter F.R.; T\u00f3th A.E.; Gr\u00f3f I.; M\u00e9sz\u00e1ros M.; Bocsik A.; Hellinger \u00c9.; Vastag M.; R\u00e1khely G.; Deli M.A.; Comparison of a rat primary cell-based blood-brain barrier model with epithelial and brain endothelial cell lines: gene expression and drug transport. Front Mol Neurosci 2018,11(166),166","journal-title":"Front Mol Neurosci"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1517\/13543784.16.12.1987","volume":"16","author":"Villarroya M.","year":"2007","unstructured":"Villarroya M.; Garc\u00eda A.G.; Marco-Contelles J.; L\u00f3pez M.G.; An update on the pharmacology of galantamine. Expert Opin Investig Drugs 2007,16(12),1987-1998","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/ACC.0b013e3182953053","volume":"1","author":"Sugi Y.","year":"2013","unstructured":"Sugi Y.; Nitahara K.; Shiroshita T.; Higa K.; Restoration of train-of-four ratio with neostigmine after insufficient recovery with sugammadex in a patient with myasthenia gravis. A A Case Rep 2013,1(3),43-45","journal-title":"A A Case Rep"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ncl.2018.01.011","volume":"36","author":"Farmakidis C.","year":"2018","unstructured":"Farmakidis C.; Pasnoor M.; Dimachkie M.M.; Barohn R.J.; Treatment of myasthenia gravis. Neurol Clin 2018,36(2),311-337","journal-title":"Neurol Clin"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0163-7258(93)90066-M","volume":"58","author":"Marrs T.C.","year":"1993","unstructured":"Marrs T.C.; Organophosphate poisoning. Pharmacol Ther 1993,58(1),51-66","journal-title":"Pharmacol Ther"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"735","DOI":"10.4103\/0972-5229.144017","volume":"18","author":"Peter J.V.","year":"2014","unstructured":"Peter J.V.; Sudarsan T.I.; Moran J.L.; Clinical features of organophosphate poisoning: A review of different classification systems and approaches. Indian J Crit Care Med 2014,18(11),735-745","journal-title":"Indian J Crit Care Med"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"17024","DOI":"10.1038\/celldisc.2017.24","volume":"3","author":"Ding Q.","year":"2017","unstructured":"Ding Q.; Fang S.; Chen X.; Wang Y.; Li J.; Tian F.; Xu X.; Attali B.; Xie X.; Gao Z.; TRPA1 channel mediates organophosphate-induced delayed neuropathy. Cell Discov 2017,3(17024),17024","journal-title":"Cell Discov"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/B978-0-444-62627-1.00010-X","volume":"131","author":"Vale A.","year":"2015","unstructured":"Vale A.; Lotti M.; Organophosphorus and carbamate insecticide poisoning. Handb Clin Neurol 2015,131,149-168","journal-title":"Handb Clin Neurol"},{"key":"ref=133","first-page":"14246","volume":"8","author":"Wang J.","year":"2015","unstructured":"Wang J.; Shao Y.; Shi K.; Yang H.; Li M.; Restricted diffusion in the splenium of the corpus callosum in organophosphate induced delayed neuropathy: case report and review of literatures. Int J Clin Exp Med 2015,8(8),14246-14250","journal-title":"Int J Clin Exp Med"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.cortex.2015.08.022","volume":"74","author":"White R.F.","year":"2016","unstructured":"White R.F.; Steele L.; O\u2019Callaghan J.P.; Sullivan K.; Binns J.H.; Golomb B.A.; Bloom F.E.; Bunker J.A.; Crawford F.; Graves J.C.; Hardie A.; Klimas N.; Knox M.; Meggs W.J.; Melling J.; Philbert M.A.; Grashow R.; Recent research on Gulf War illness and other health problems in veterans of the 1991 Gulf War: Effects of toxicant exposures during deployment. Cortex 2016,74,449-475","journal-title":"Cortex"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ntt.2013.10.002","volume":"40","author":"Abdullah L.","year":"2013","unstructured":"Abdullah L.; Evans J.E.; Montague H.; Reed J.M.; Moser A.; Crynen G.; Gonzalez A.; Zakirova Z.; Ross I.; Mullan C.; Mullan M.; Ait-Ghezala G.; Crawford F.; Chronic elevation of phosphocholine containing lipids in mice exposed to Gulf War agents pyridostigmine bromide and permethrin. Neurotoxicol Teratol 2013,40,74-84","journal-title":"Neurotoxicol Teratol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bbr.2009.05.002","volume":"203","author":"Amourette C.","year":"2009","unstructured":"Amourette C.; Lamproglou I.; Barbier L.; Fauquette W.; Zoppe A.; Viret R.; Diserbo M.; Gulf War illness: Effects of repeated stress and pyridostigmine treatment on blood-brain barrier permeability and cholinesterase activity in rat brain. Behav Brain Res 2009,203(2),207-214","journal-title":"Behav Brain Res"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"Ellman G.L.","year":"1961","unstructured":"Ellman G.L.; Courtney K.D.; Andres V.; Feather-Stone R.M.; A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961,7,88-95","journal-title":"Biochem Pharmacol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/clinchem\/29.2.365","volume":"29","author":"George P.M.","year":"1983","unstructured":"George P.M.; Abernethy M.H.; Improved Ellman procedure for erythrocyte cholinesterase. Clin Chem 1983,29(2),365-368","journal-title":"Clin Chem"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1080\/00032719.2013.780240","volume":"46","author":"Pohanka M.","year":"2013","unstructured":"Pohanka M.; Cholinesterases in biorecognition and biosensor construction, a review. Anal Lett 2013,46(12),1849-1868","journal-title":"Anal Lett"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1515\/chempap-2015-0117","volume":"69","author":"Pohanka M.","year":"2015","unstructured":"Pohanka M.; Determination of acetylcholinesterase and butyrylcholinesterase activity without dilution of biological samples. Chem Pap 2015,69(8),1044-1049","journal-title":"Chem Pap"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ecoenv.2013.07.022","volume":"97","author":"Oropesa A.L.","year":"2013","unstructured":"Oropesa A.L.; Gravato C.; S\u00e1nchez S.; Soler F.; Characterization of plasma cholinesterase from the White stork (Ciconia ciconia) and its in vitro inhibition by anticholinesterase pesticides. Ecotoxicol Environ Saf 2013,97,131-138","journal-title":"Ecotoxicol Environ Saf"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4103\/0019-5278.111755","volume":"16","author":"Dhananjayan V.","year":"2012","unstructured":"Dhananjayan V.; Ravichandran B.; Anitha N.; Rajmohan H.R.; Assessment of acetylcholinesterase and butyrylcholinesterase activities in blood plasma of agriculture workers. Indian J Occup Environ Med 2012,16(3),127-130","journal-title":"Indian J Occup Environ Med"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/jat.1526","volume":"30","author":"Li B.","year":"2010","unstructured":"Li B.; Ricordel I.; Schopfer L.M.; Baud F.; M\u00e9garbane B.; Masson P.; Lockridge O.; Dichlorvos, chlorpyrifos oxon and Aldicarb adducts of butyrylcholinesterase, detected by mass spectrometry in human plasma following deliberate overdose. J Appl Toxicol 2010,30(6),559-565","journal-title":"J Appl Toxicol"},{"key":"ref=144","first-page":"726","volume":"114","author":"Pohanka M.","year":"2013","unstructured":"Pohanka M.; Butyrylcholinesterase as a biochemical marker. Bratisl Lek Listy 2013,114(12),726-734","journal-title":"Bratisl Lek Listy"},{"key":"ref=145","first-page":"515","volume":"25","author":"Jezyna C.","year":"1969","unstructured":"Jezyna C.; [Correlation of chnges in hypocholinesterasemia and hypoalbuminemia in virus hepatitis]. Przegl Lek 1969,25(7),515-519","journal-title":"Przegl Lek"},{"key":"ref=146","first-page":"795","volume":"19","author":"Tomaszewska L.","year":"1966","unstructured":"Tomaszewska L.; Schmidt E.; [Activity of serum cholinesterase in certain liver diseases, particularly in virus hepatitis]. Wiad Lek 1966,19(10),795-798","journal-title":"Wiad Lek"},{"key":"ref=147","first-page":"859","volume":"49","author":"Tamarelle C.","year":"1973","unstructured":"Tamarelle C.; Quinton A.; Bancons J.; Dubarry J.J.; [Serum cholinesterase, test of liver cell failure]. Sem Hop 1973,49(12),859-864","journal-title":"Sem Hop"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1055\/s-0028-1108487","volume":"95","author":"Fintelmann V.","year":"1970","unstructured":"Fintelmann V.; Lindner H.; [Diagnostic significance of serum cholinesterase in liver diseases]. Dtsch Med Wochenschr 1970,95(9),469-470","journal-title":"Dtsch Med Wochenschr"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1600-0609.1987.tb00747.x","volume":"39","author":"Kemkes-Matthes B.","year":"1987","unstructured":"Kemkes-Matthes B.; Preissner K.T.; Langenscheidt F.; Matthes K.J.; M\u00fcller-Berghaus G.; S protein\/vitronectin in chronic liver diseases: correlations with serum cholinesterase, coagulation factor X and complement component C3. Eur J Haematol 1987,39(2),161-165","journal-title":"Eur J Haematol"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2169\/internalmedicine.36.9","volume":"36","author":"Liu W.","year":"1997","unstructured":"Liu W.; Hada T.; Fukui K.; Imanishi H.; Matsuoka N.; Iwasaki A.; Higashino K.; Familial hypocholinesterasemia found in a family and a new confirmed mutation. Intern Med 1997,36(1),9-13","journal-title":"Intern Med"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/BF02774688","volume":"18","author":"Tajiri J.","year":"1983","unstructured":"Tajiri J.; Nishizono Y.; Fujiyama S.; Sagara K.; Sato T.; Shibata H.; Hypercholinesterasemia in patients with hepatocellular carcinoma: a new paraneoplastic syndrome. Gastroenterol Jpn 1983,18(2),137-141","journal-title":"Gastroenterol Jpn"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3233\/JAD-150750","volume":"50","author":"Vijayaraghavan S.","year":"2016","unstructured":"Vijayaraghavan S.; Darreh-Shori T.; Rongve A.; Berge G.; Sando S.B.; White L.R.; Auestad B.H.; Witoelar A.; Andreassen O.A.; Ulstein I.D.; Aarsland D.; Association of butyrylcholinesterase-K allele and apolipoprotein E \u025b4 allele with cognitive decline in dementia with lewy bodies and alzheimer\u2019s disease. J Alzheimers Dis 2016,50(2),567-576","journal-title":"J Alzheimers Dis"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3233\/JAD-160373","volume":"54","author":"De Beaumont L.","year":"2016","unstructured":"De Beaumont L.; Pelleieux, S.; Lamarre-Theroux, L.; Dea, D.; Poirier, J., Butyrylcholinesterase K and Apolipoprotein E-varepsilon4 reduce the age of onset of alzheimer\u2019s disease, accelerate cognitive decline, and modulate donepezil response in mild cognitively impaired subjects. J Alzheimers Dis 2016,54(3),913-922","journal-title":"J Alzheimers Dis"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3233\/JAD-160562","volume":"56","author":"Sokolow S.","year":"2017","unstructured":"Sokolow S.; Li X.; Chen L.; Taylor K.D.; Rotter J.I.; Rissman R.A.; Aisen P.S.; Apostolova L.G.; Deleterious effect of butyrylcholinesterase K-variant in donepezil treatment of mild cognitive impairment. J Alzheimers Dis 2017,56(1),229-237","journal-title":"J Alzheimers Dis"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2147\/CIA.S137264","volume":"12","author":"Pongthanaracht N.","year":"2017","unstructured":"Pongthanaracht N.; Yanarojana S.; Pinthong D.; Unchern S.; Thithapandha A.; Assantachai P.; Supavilai P.; Association between butyrylcholinesterase K variant and mild cognitive impairment in the Thai community-dwelling patients. Clin Interv Aging 2017,12,897-901","journal-title":"Clin Interv Aging"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1139\/y04-030","volume":"82","author":"Vahdati-Mashhadian N.","year":"2004","unstructured":"Vahdati-Mashhadian N.; Hassanzadeh M.K.; Hosseini J.; Saffareshargh A.A.; Ethnic differences in the frequency of distribution of serum cholinesterase activity in the Iranian population. Can J Physiol Pharmacol 2004,82(5),326-330","journal-title":"Can J Physiol Pharmacol"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s001250100033","volume":"44","author":"Hashim Y.","year":"2001","unstructured":"Hashim Y.; Shepherd D.; Wiltshire S.; Holman R.R.; Levy J.C.; Clark A.; Cull C.A.; Butyrylcholinesterase K variant on chromosome 3 q is associated with Type II diabetes in white Caucasian subjects. Diabetologia 2001,44(12),2227-2230","journal-title":"Diabetologia"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cca.2006.11.005","volume":"378","author":"Manoharan I.","year":"2007","unstructured":"Manoharan I.; Boopathy R.; Darvesh S.; Lockridge O.; A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India. Clin Chim Acta 2007,378(1-2),128-135","journal-title":"Clin Chim Acta"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/BF03011943","volume":"44","author":"Krasowski M.D.","year":"1997","unstructured":"Krasowski M.D.; McGehee D.S.; Moss J.; Natural inhibitors of cholinesterases: implications for adverse drug reactions. Can J Anaesth 1997,44(5 Pt 1),525-534","journal-title":"Can J Anaesth"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1021\/acs.chemrestox.6b00228","volume":"29","author":"Lockridge O.","year":"2016","unstructured":"Lockridge O.; Norgren R.B.; Johnson R.C.; Blake T.A.; Naturally occurring genetic variants of human acetylcholinesterase and butyrylcholinesterase and their potential impact on the risk of toxicity from cholinesterase inhibitors. Chem Res Toxicol 2016,29(9),1381-1392","journal-title":"Chem Res Toxicol"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cbi.2012.09.008","volume":"203","author":"Sim\u00e3o-Silva D.P.","year":"2013","unstructured":"Sim\u00e3o-Silva D.P.; Bertolucci P.H.; de Labio R.W.; Pay\u00e3o S.L.; Furtado-Alle L.; Souza R.L.; Association analysis between K and -116A variants of butyrylcholinesterase and Alzheimer\u2019s disease in a Brazilian population. Chem Biol Interact 2013,203(1),358-360","journal-title":"Chem Biol Interact"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1080\/00365510260296537","volume":"62","author":"G\u00e4tke M.R.","year":"2002","unstructured":"G\u00e4tke M.R.; Viby-Mogensen J.; Bundgaard J.R.; Rapid simultaneous genotyping of the frequent butyrylcholinesterase variants Asp70Gly and Ala539Thr with fluorescent hybridization probes. Scand J Clin Lab Invest 2002,62(5),375-383","journal-title":"Scand J Clin Lab Invest"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.annfar.2006.02.009","volume":"25","author":"Lejus C.","year":"2006","unstructured":"Lejus C.; Delaroche O.; Trille E.; Blanloeil Y.; Pinaud M.; [Butyrylcholinesterase deficiency: how to analyse the cholinesterase activity in small children?]. Ann Fr Anesth Reanim 2006,25(6),657-660","journal-title":"Ann Fr Anesth Reanim"},{"key":"ref=164","first-page":"1104","volume":"50","author":"Bartels C.F.","year":"1992","unstructured":"Bartels C.F.; James K.; La Du B.N.; DNA mutations associated with the human butyrylcholinesterase J-variant. Am J Hum Genet 1992,50(5),1104-1114","journal-title":"Am J Hum Genet"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1042\/bj0990133","volume":"99","author":"Cimasoni G.","year":"1966","unstructured":"Cimasoni G.; Inhibition of cholinesterases by fluoride in vitro. Biochem J 1966,99(1),133-137","journal-title":"Biochem J"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1515\/CCLM.2003.051","volume":"41","author":"Mosca A.","year":"2003","unstructured":"Mosca A.; Bonora R.; Ceriotti F.; Franzini C.; Lando G.; Patrosso M.C.; Zaninotto M.; Panteghini M.; Italian society of clinical biochemistry and clinical molecular biology working group on enzymes. Assay using succinyldithiocholine as substrate: the method of choice for the measurement of cholinesterase catalytic activity in serum to diagnose succinyldicholine sensitivity. Clin Chem Lab Med 2003,41(3),317-322","journal-title":"Clin Chem Lab Med"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.cbi.2016.04.030","volume":"259","author":"Jasiecki J.","year":"2016","unstructured":"Jasiecki J.; Jonca J.; Zuk M.; Szczoczarz A.; Janaszak-Jasiecka A.; Lewandowski K.; Waleron K.; Wasag B.; Activity and polymorphisms of butyrylcholinesterase in a Polish population. Chem Biol Interact 2016,259(Pt B),70-77","journal-title":"Chem Biol Interact"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/CH-2011-1520","volume":"51","author":"de Oliveira P.","year":"2012","unstructured":"de Oliveira P.; Gomes A.Q.; Pacheco T.R.; Vitorino de Almeida V.; Saldanha C.; Calado A.; Cell-specific regulation of acetylcholinesterase expression under inflammatory conditions. Clin Hemorheol Microcirc 2012,51(2),129-137","journal-title":"Clin Hemorheol Microcirc"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1042\/CS20070393","volume":"115","author":"Mart\u00ednez-L\u00f3pez de Castro A.","year":"2008","unstructured":"Mart\u00ednez-L\u00f3pez de Castro A.; Nieto-Cer\u00f3n S.; Aurelio P.C.; Galbis-Mart\u00ednez L.; Latour-P\u00e9rez J.; Torres-Lanzas J.; Tovar-Zapata I.; Mart\u00ednez-Hern\u00e1ndez P.; Rodr\u00edguez-L\u00f3pez J.N.; Cabezas-Herrera J.; Cancer-associated differences in acetylcholinesterase activity in bronchial aspirates from patients with lung cancer. Clin Sci (Lond) 2008,115(8),245-253","journal-title":"Clin Sci (Lond)"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/1759-7714.12249","volume":"6","author":"Xi H.J.","year":"2015","unstructured":"Xi H.J.; Wu R.P.; Liu J.J.; Zhang L.J.; Li Z.S.; Role of acetylcholinesterase in lung cancer. Thorac Cancer 2015,6(4),390-398","journal-title":"Thorac Cancer"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2174\/156720510790274455","volume":"7","author":"Darreh-Shori T.","year":"2010","unstructured":"Darreh-Shori T.; Soininen H.; Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer\u2019s disease: a review of recent clinical studies. Curr Alzheimer Res 2010,7(1),67-73","journal-title":"Curr Alzheimer Res"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/156720509787313961","volume":"6","author":"Nordberg A.","year":"2009","unstructured":"Nordberg A.; Darreh-Shori T.; Peskind E.; Soininen H.; Mousavi M.; Eagle G.; Lane R.; Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients. Curr Alzheimer Res 2009,6(1),4-14","journal-title":"Curr Alzheimer Res"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1016\/S0047-6374(01)00314-1","volume":"122","author":"Amici S.","year":"2001","unstructured":"Amici S.; Lanari A.; Romani R.; Antognelli C.; Gallai V.; Parnetti L.; Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina. Mech Ageing Dev 2001,122(16),2057-2062","journal-title":"Mech Ageing Dev"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1007\/s100720200086","volume":"23","author":"Parnetti L.","year":"2002","unstructured":"Parnetti L.; Amici S.; Lanari A.; Romani C.; Antognelli C.; Andreasen N.; Minthon L.; Davidsson P.; Pottel H.; Blennow K.; Gallai V.; Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors. Neurol Sci 2002,23(2)(Suppl. 2),S95-S96","journal-title":"Neurol Sci"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1600-0404.2010.01435.x","volume":"124","author":"Parnetti L.","year":"2011","unstructured":"Parnetti L.; Chiasserini D.; Andreasson U.; Ohlson M.; H\u00fcls C.; Zetterberg H.; Minthon L.; Wallin A.K.; Andreasen N.; Talesa V.N.; Blennow K.; Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer\u2019s disease. Acta Neurol Scand 2011,124(2),122-129","journal-title":"Acta Neurol Scand"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/169484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T07:19:02Z","timestamp":1662880742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/169484\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,3]]},"references-count":175,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2020,6,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867326666190130161202","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-07-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}